- Home
- SFWL vs BEAT Comparison
SFWL vs BEAT Comparison
Compare SFWL & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- BEAT
- Stock Information
- Founded
- SFWL 2001
- BEAT 2015
- Country
- SFWL China
- BEAT United States
- Employees
- SFWL N/A
- BEAT N/A
- Industry
- SFWL Trucking Freight/Courier Services
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- SFWL Industrials
- BEAT Technology
- Exchange
- SFWL Nasdaq
- BEAT Nasdaq
- Market Cap
- SFWL 91.6M
- BEAT 74.1M
- IPO Year
- SFWL 2023
- BEAT 2021
- Fundamental
- Price
- SFWL $1.11
- BEAT $2.24
- Analyst Decision
- SFWL
- BEAT Buy
- Analyst Count
- SFWL 0
- BEAT 1
- Target Price
- SFWL N/A
- BEAT $8.00
- AVG Volume (30 Days)
- SFWL 34.5K
- BEAT 277.5K
- Earning Date
- SFWL 09-04-2024
- BEAT 11-07-2024
- Dividend Yield
- SFWL N/A
- BEAT N/A
- EPS Growth
- SFWL N/A
- BEAT N/A
- EPS
- SFWL 0.11
- BEAT N/A
- Revenue
- SFWL $446,281,000.00
- BEAT N/A
- Revenue This Year
- SFWL N/A
- BEAT N/A
- Revenue Next Year
- SFWL N/A
- BEAT N/A
- P/E Ratio
- SFWL $10.30
- BEAT N/A
- Revenue Growth
- SFWL 14.80
- BEAT N/A
- 52 Week Low
- SFWL $0.81
- BEAT $1.35
- 52 Week High
- SFWL $2.99
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- SFWL 49.24
- BEAT 37.78
- Support Level
- SFWL $1.01
- BEAT $2.16
- Resistance Level
- SFWL $1.07
- BEAT $2.54
- Average True Range (ATR)
- SFWL 0.06
- BEAT 0.26
- MACD
- SFWL 0.01
- BEAT -0.06
- Stochastic Oscillator
- SFWL 68.75
- BEAT 6.06
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. The company offers contract logistics services comprising planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The integrated logistics solution services of the company are comprised of three segments: B2B freight transportation; cloud storage; and value-added services.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.